Stay updated on Nivolumab for Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Prostate Cancer Clinical Trial page.

Latest updates to the Nivolumab for Prostate Cancer Clinical Trial page
- Check4 days agoChange DetectedA related MedlinePlus Genetics resource about prostate cancer is listed alongside the study’s other educational links.SummaryDifference0.2%

- Check11 days agoChange DetectedThe clinical trial record for the ImmunoProst study of nivolumab in prostate cancer is displayed, with details on study design, participant eligibility, locations, and outcome measures.SummaryDifference49%

- Check18 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2. The study record remains unavailable and displays a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedA sitewide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check32 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check39 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 on the ClinicalTrials.gov 403 error page.SummaryDifference0.2%

Stay in the know with updates to Nivolumab for Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Prostate Cancer Clinical Trial page.